{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,23]],"date-time":"2026-01-23T08:52:42Z","timestamp":1769158362010,"version":"3.49.0"},"reference-count":15,"publisher":"Wiley","issue":"1","license":[{"start":{"date-parts":[[2009,1,2]],"date-time":"2009-01-02T00:00:00Z","timestamp":1230854400000},"content-version":"vor","delay-in-days":1462,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["The Laryngoscope"],"published-print":{"date-parts":[[2005,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>\n                    <jats:bold>Objectives:<\/jats:bold>\n                    To determine if human immunodeficiency virus (HIV) infection is associated with a prolonged mucociliary clearance time (MCT) and to evaluate the effect of guaifenesin on MCT in HIV+ patients.\n                  <\/jats:p>\n                  <jats:p>\n                    <jats:bold>Study Design:<\/jats:bold>\n                    A cross\u2010sectional study comparing HIV+ and HIV\u2212 volunteers followed by a prospective, randomized, double\u2010blind, placebo\u2010controlled study of HIV+ patients before and after guaifenesin treatment.\n                  <\/jats:p>\n                  <jats:p>\n                    <jats:bold>Methods:<\/jats:bold>\n                    Twenty\u2010five HIV+ patients and 29 HIV\u2212 controls were enrolled and MCT was measured using the saccharin method. A separate group of 20 HIV+ patients participated in the second arm of the study and underwent saccharin testing before and after a 3\u2010week course of guaifenesin or placebo. All study participants completed a medical history questionnaire, a sinonasal symptom (SNOT\u201016) survey, and were examined with both anterior rhinoscopy and rigid nasal endoscopy.\n                  <\/jats:p>\n                  <jats:p>\n                    <jats:bold>Results:<\/jats:bold>\n                    There was a significant difference (\n                    <jats:italic>P<\/jats:italic>\n                    &lt; .002) in the MCT between the HIV+ group (13.3 \u00b1 SD 7.5 minutes) and the HIV\u2212 controls (9.2 \u00b1 SD 3.9 minutes). The difference in MCT between the guaifenesin and placebo groups did not reach statistical significance (\n                    <jats:italic>P<\/jats:italic>\n                    &gt;.05). The HIV+ group had a higher SNOT\u201016 score compared to HIV\u2212 controls (21.1 vs. 7.4,\n                    <jats:italic>P<\/jats:italic>\n                    &lt; .001). Guaifenesin therapy in HIV+ patients led to a significant improvement in the SNOT\u201016 score (\n                    <jats:italic>P<\/jats:italic>\n                    &lt; .05).\n                  <\/jats:p>\n                  <jats:p>\n                    <jats:bold>Conclusions:<\/jats:bold>\n                    Compared to HIV\u2212 controls, HIV+ patients have a prolonged MCT and more sinonasal symptoms as indicated by a higher SNOT\u201016 score. Guaifenesin therapy was associated with improved SNOT\u201016 scores, although there was not a detectable improvement in MCT. Use of guaifenesin in HIV+ patients with sinonasal disease may lead to improved patient perception of quality of life\n                  <\/jats:p>","DOI":"10.1097\/01.mlg.0000150678.83602.d4","type":"journal-article","created":{"date-parts":[[2009,2,19]],"date-time":"2009-02-19T16:38:05Z","timestamp":1235061485000},"page":"27-30","source":"Crossref","is-referenced-by-count":25,"title":["Alterations of Nasal Mucociliary Clearance in Association with HIV Infection and the Effect of Guaifenesin Therapy"],"prefix":"10.1002","volume":"115","author":[{"given":"Elizabeth J.","family":"Rosen","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Karen H.","family":"Calhoun","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2009,1,2]]},"reference":[{"key":"e_1_2_6_2_2","first-page":"1","volume":"14","author":"Centers for Disease Control and Prevention","year":"2002","journal-title":"HIV\/AIDS Surveillance Report"},{"key":"e_1_2_6_3_2","first-page":"11","article-title":"HIV sinusitis: rationale for a treatment algorithm","volume":"151","author":"Belafsky P","year":"1999","journal-title":"J La State Med Soc"},{"key":"e_1_2_6_4_2","first-page":"460","article-title":"Sinusitis in patients with the acquired immunodeficiency syndrome","volume":"69","author":"Rubin JS","year":"1990","journal-title":"Ear Nose Throat J"},{"key":"e_1_2_6_5_2","doi-asserted-by":"publisher","DOI":"10.1288\/00005537-199511000-00012"},{"key":"e_1_2_6_6_2","doi-asserted-by":"publisher","DOI":"10.1288\/00005537-199211000-00004"},{"key":"e_1_2_6_7_2","doi-asserted-by":"publisher","DOI":"10.1080\/00039896.1974.10666589"},{"key":"e_1_2_6_8_2","doi-asserted-by":"publisher","DOI":"10.1136\/thx.36.9.654"},{"key":"e_1_2_6_9_2","doi-asserted-by":"publisher","DOI":"10.2500\/105065898782102945"},{"key":"e_1_2_6_10_2","first-page":"155","article-title":"Effect of surface\u2010active substance on nasal mucociliary clearance time: a comparison of saccharin clearance time before and after the use of surface\u2010active substance","volume":"31","author":"Outzen KE","year":"1993","journal-title":"Rhinology"},{"key":"e_1_2_6_11_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2273.1986.tb01994.x"},{"key":"e_1_2_6_12_2","doi-asserted-by":"publisher","DOI":"10.1017\/S0022215100094457"},{"key":"e_1_2_6_13_2","doi-asserted-by":"publisher","DOI":"10.3109\/00016488509126571"},{"key":"e_1_2_6_14_2","doi-asserted-by":"publisher","DOI":"10.1177\/014556139507400512"},{"key":"e_1_2_6_15_2","doi-asserted-by":"publisher","DOI":"10.1053\/hn.1999.v121.a100114"},{"key":"e_1_2_6_16_2","doi-asserted-by":"publisher","DOI":"10.1378\/chest.107.3.747"}],"container-title":["The Laryngoscope"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1097%2F01.mlg.0000150678.83602.d4","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1097\/01.mlg.0000150678.83602.d4","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,29]],"date-time":"2025-12-29T16:32:31Z","timestamp":1767025951000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1097\/01.mlg.0000150678.83602.d4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2005,1]]},"references-count":15,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2005,1]]}},"alternative-id":["10.1097\/01.mlg.0000150678.83602.d4"],"URL":"https:\/\/doi.org\/10.1097\/01.mlg.0000150678.83602.d4","archive":["Portico"],"relation":{},"ISSN":["0023-852X","1531-4995"],"issn-type":[{"value":"0023-852X","type":"print"},{"value":"1531-4995","type":"electronic"}],"subject":[],"published":{"date-parts":[[2005,1]]}}}